Profilo
Piet van Waes worked as an Investment Manager at Partners at Venture (Private Equity) from 2005 to 2008.
Precedenti posizioni note di Piet van Waes
| Società | Posizione | Fine |
|---|---|---|
Partners at Venture (Private Equity)
Partners at Venture (Private Equity) Investment ManagersFinance Partners' venture capital investment strategy targets SME firms active in a range of sectors including information technology and communication, life sciences and environmental technology. They supply capital and provide active support in the development of their portfolio firms. They typically take minority interests. Partners has made investments in segments such as consumer electronics, medical and healthcare products and pharmaceutical raw materials, pet and production animal pharmaceuticals, ERP package for SMEs, software application in engineering and project management, dental surgery planning and simulation software, cartilage regenerative medication, digital cinemas systems, and online learning solutions. | Investitore di Private Equity | 31/12/2008 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Partners at Venture (Private Equity)
Partners at Venture (Private Equity) Investment ManagersFinance Partners' venture capital investment strategy targets SME firms active in a range of sectors including information technology and communication, life sciences and environmental technology. They supply capital and provide active support in the development of their portfolio firms. They typically take minority interests. Partners has made investments in segments such as consumer electronics, medical and healthcare products and pharmaceutical raw materials, pet and production animal pharmaceuticals, ERP package for SMEs, software application in engineering and project management, dental surgery planning and simulation software, cartilage regenerative medication, digital cinemas systems, and online learning solutions. | Finance |
















